Since some of these genes encode metabolic enzymes, IFN-γ exposure alters cancer metabolism; for example, indoleamine 2,3-dioxygenase 1 (IDO1) induced by IFN-γ is the rate-limiting enzyme of tryptophan catabolism via the kynurenine pathway. The gene discussed is IDO1; the disease is cancer.